Back To Search
Russell C Langan MD

Russell C. Langan, MD

  • Surgery-General | Surgery-Oncology
  • Member of Our Medical Group
Languages Spoken English
See This Doctor
  • At A Glance
  • Education
  • Profile Video

    Russell Charles Langan, MD, is a Board Certified Surgical Oncologist who joined Saint Barnabas Medical Center in a dual appointment with the Rutgers Cancer Institute of New Jersey. Dr. Langan specializes in complex surgical oncology and has particular interest and expertise in the surgical management in diseases of the liver, pancreas, bile ducts and stomach as well as cancers which have spread to the peritoneum. Additionally, he cares for all benign biliary pathologies. He strives to provide the highest level of expertise and precision with unwavering compassion, optimism and hope to his patients and their families.

    Dr. Langan is the Chair of the Saint Barnabas Medical Center Institutional Review Board (IRB) and the Surgical Director of the Comprehensive Liver Center. As a member of both Saint Barnabas Medical Center and the Gastrointestinal/Hepatobiliary Program at the Rutgers Cancer Institute of New Jersey, he works collaboratively with members of the multidisciplinary disease management teams including medical oncologists, radiation oncologists, gastroenterologists, radiologists, pathologists, genetic counselors and dietitians to ensure his patients receive the highest level of evidence-based care including clinical trials. Here at SBMC, Dr. Langan will be launching a Pancreatic Cyst Screening program to monitor pancreatic lesions which do not merit immediate removal but require observation.

    Prior to joining our staff, Dr. Langan completed his general surgery residency at Saint Barnabas Medical Center as well as Georgetown University Hospital. He completed fellowships in Tumor Immunotherapy and Surgical Oncology under Steven Rosenberg, MD, at the National Cancer Institute, National Institutes of Health (NCI,NIH). More recently, Dr. Langan completed a fellowship in complex general surgical oncology at Memorial Sloan Kettering Cancer Center where he received specialized training in the surgical management of hepatobiliary and pancreatic cancers.

    Dr. Langan has authored over 30 peer-reviewed articles and 7 book chapters dedicated to surgical oncology. Within his field, he has lectured and presented nationally and while at the NCI,NIH, he was an associate investigator on numerous clinical trials.

    Dr. Langan is a member of the American College of Surgeons, Society of Surgical Oncology, Regional Cancer Therapies, American Hepatopancreatobiliary Association and the Association for Academic Surgery. Dr. Langan has received awards from the National Institutes of Health, Health and Human Services (Recognition for Special Act and Service), Georgetown University Hospital, DC Chapter of the American College of Surgeons, Society of Black Academic Surgeons, the Marquis Who’s Who award in 2015 and the Top Doctor Award for surgical oncology in New York, New York for 2016 from The Top Doctor Award.

    Dr. Langan recognizes the paramount importance of oncologic research on clinical outcomes and has continued to publish and present at local and national conferences. Here at SBMC he has established hepatopancreatobiliary enhanced recovery after surgery (ERAS) protocols and continues to participate in clinical trials to further enhance the care of the cancer patient.

    Clinical Interests

    Hepatopancreatobiliary Surgery, Pancreatic Cancer and Cysts, Liver Cancer, Metastatic Colorectal Cancer to the Liver, Gallbladder & Bile Duct Cancers, Gastrointestinal Neuroendocrine Tumors, Gastric Cancer, Minimally Invasive / Robotic Surgery

  • Medical School

    Saint George’s University School of Medicine, 2007


    General Surgery - Saint Barnabas Medical Center, Livingston, NJ, 2009 General Surgery - Georgetown University Hospital, Washington, DC, 2015


    Surgical Oncology - Memorial Sloan Kettering Cancer Center, New York, New York, 2017 Tumor Immunotherapy and Surgical Oncology - National Cancer Institute, National Institutes of Health (NIH), Bethesda, MD, 2012